Clinical Trials Browser

Phase 3 × INDUSTRY × sugemalimab × Clear all

NCT05700448 2026-05-27

Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma

Phase 3 Not yet recruiting

Lymphoma, Extranodal NK-T-Cell

NCT06617416 2025-03-12

A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung